Adamis Pharmaceuticals Corporation · Del Mar, CA United States (OTC: ADMP)
| 2658 Del Mar Heights Rd., No. 555 | Phone: 858-401-3984 |
| Del Mar, CA | |
| 92014 | |
| United States | 
Map This Company |
Adamis Pharmaceuticals Corporation Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Adamis Pharmaceuticals adamantly develops and markets specialty prescription drugs for respiratory ailments, allergies, viral infections, and other medical conditions. Subsidiary Adamis Labs develops and markets allergy, respiratory, and pediatric prescription medicines to physicians in the US. Its products include a pre-filled epinephrine syringe for severe allergic reactions dubbed Epi PFS. Adamis Viral Therapies is developing vaccine technologies for ailments such as influenza and hepatitis. The company is also developing Savvy, a contraceptive gel, and other candidates to potentially treat prostate cancer.
Adamis Pharmaceuticals Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: ADMP Headquarters |
|---|---|
| Fiscal Year-End | March |
| Employees | 9 |
Executives
10 executives listed for Adamis Pharmaceuticals Corporation's Del Mar, CA location.
| President , CEO, and Director | Dennis Carlo | |
|---|---|---|
| CFO and Secretary | Robert Hopkins | |
| VP Business Development and Investor Relations, and Director | David Marguglio |